Kitazato

Kitazato Days Payable Outstanding

The Days Payable Outstanding (DPO) of Kitazato (368A.T) as of Nov 17, 2026 is 27.65. In the previous year, Days Payable Outstanding (DPO) was 16.21 — a change of 70.56% (higher).

Days Payable Outstanding

27.65

YoY

70.56%

Last updated:

Days Payable Outstanding (DPO) of Kitazato is 2025 27.65 . Days Payable Outstanding (DPO) of Kitazato was 2024 16.21 . It decreases by 70.56% higher compared to the previous year.

The Kitazato Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2023
23.13 JPY
Jan 1, 2024
16.21 JPY
Jan 1, 2025
27.65 JPY
The Kitazato Days Payable Outstanding history
YEARDays Payable OutstandingYoY
27.65+70.56%
16.21-29.93%
23.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Days Payable Outstanding (DPO) of Kitazato is 27.65 in 2025.

Days Payable Outstanding (DPO) of Kitazato changed from 16.21 to 27.65, representing a 70.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Kitazato since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Kitazato with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Kitazato

All Key Metrics — Kitazato